Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 175

The DOI matches its Crossref record.

Interferon for the Treatment of Chronic Hepatitis C in Patients Infected with Human Immunodeficiency Virus

Open access
Soriano, V., Garcia-Samaniego, J., Bravo, R., Gonzalez, J., Castro, A., Castilla, J., Martinez-Odriozola, P., Colmenero, M., Carballo, E., Suarez, D., Rodriguez-Pinero, F. J., Moreno, A., Romero, J. d., Pedreira, J., Gonzalez-Lahoz, J., Hepatitis-HIV Spanish Study Group·1996·Clinical Infectious Diseases

Abstract

Liver disease secondary to hepatitis C virus (HCV) infection is a rising cause of morbidity and mortality among individuals who have been infected parenterally with human immunodeficiency virus (HIV) such as injection drug users, hemophiliacs, and transfused patients. We analyzed both the efficacy of interferon (IFN) alpha therapy in these patients and the predictors of response to this agent. A total of 119 patients with chronic hepatitis C (90 of whom were infected with HIV and 29 of whom were not) were included in a multicenter, prospective, open, nonrandomized observational study. IFN-alpha was given subcutaneously in a dosage of 5 million units three times a week during a 3-month period; those patients who responded received a dose of 3 million units given subcutaneously three times a week for an additional 9 months. One hundred seven patients completed the study; the level of aminotransferases returned to normal and sera became negative (complete response) for HCV RNA in 26 (32.5%) of 80 HIV-infected patients and 10 (37.0%) of 27 non-HIV-infected patients (P = .666) after completion of the treatment. Two variables were independently associated with a response in HIV-infected patients: a CD4+ T lymphocyte count of > 500 x 10(6)/L and a baseline HCV viremia level of < 10(7) copies/mL. In the 12 months following treatment, relapses occurred in 30.8% of the HIV-infected patients and 12.5% of non-HIV-infected patients (P = .403).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/clinids/23.3.585

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 175

Metadata

Authors
Soriano, V., Garcia-Samaniego, J., Bravo, R., Gonzalez, J., Castro, A., Castilla, J., Martinez-Odriozola, P., Colmenero, M., Carballo, E., Suarez, D., Rodriguez-Pinero, F. J., Moreno, A., Romero, J. D., Pedreira, J., Gonzalez-Lahoz, J., & Hepatitis-HIV Spanish Study Group
Venue
Clinical Infectious Diseases
Published
1996-09-01
Volume
23
Issue
3
Pages
585-591
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W1987268569
Cited by
175
References
0
FWCI
3.91
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interferon for the Treatment of Chronic Hepatitis C in Patients Infected with Human Immunodeficiency Virus. https://app.cochat.ai/papers/10.1093/clinids/23.3.585
The paper
Soriano, V., Garcia-Samaniego, J., Bravo, R., Gonzalez, J., Castro, A., Castilla, J., Martinez-Odriozola, P., Colmenero, M., Carballo, E., Suarez, D., Rodriguez-Pinero, F. J., Moreno, A., Romero, J. D., Pedreira, J., Gonzalez-Lahoz, J., & Hepatitis-HIV Spanish Study Group. (1996). Interferon for the Treatment of Chronic Hepatitis C in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. https://doi.org/10.1093/clinids/23.3.585

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.